Kevin O’Neill is an experienced leader and strategist with 25 years of biopharma commercialization experience. Over the last 10 years, Kevin has worked with a wide range of vaccine developers in various disease states providing strategic guidance and developing strategies for successful commercialization. Prior to his consulting experience, Kevin was Vice President and Global Manager of adult vaccines at Pfizer Vaccines where he led the global commercialization effort for Prevnar 13®. Mr. O’Neill has also led product launch efforts in flu vaccines, arthritis, gastrointestinal, diabetes and nutritional products.